Briefing
Use of ultra-sensitive whole genome circulating tumor DNA detection to predict early recurrence in high-risk localized RCC after nephrectomy: Preliminary real-world findings.
Among 22 people with high-risk localized renal cell carcinoma tested with Next Personal Dx after nephrectomy, 3 had ctDNA detected and 2 of those recurred, while none of 16 with persistent ctDNA negativity recurred during follow-up.
- Design: Abstract 516
- Assay: NeXT Personal